Barely Significant
← all excerpts

Comparison of osteoanabolic agents (teriparatide and romosozumab) with bisphosphonates in prevention of subsequent vertebral fractures in patients treated for osteoporotic vertebral fracture for 12 months: An observational cohort study.

Bone Rep · 2024 · PMC11033177 · PMID 38650912

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Although there was no statistically significant difference in subsequent domino OVF among the three groups, the Romo group showed a trend toward more use of soft bracing (63 %) than the BP (47 %) or TPTD (44 %) groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.